Skip to main content

Human Trials of Bharat Biotech’s COVID-19 Nasal-drop Vaccine to Begin in 4 Months M

In India, Hyderabad-based vaccine manufacturer, Bharat Biotech, which has been working on developing a intra-nasal drop vaccine for COVID-19, has initiated testing in the US in collaboration with the University of Wisconsin-Madison and vaccine developer FluGen, CNBC-TV18 reported.